Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00470392 · ClinicalTrials.gov registry record · NA
Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
A NA study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00470392: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT00470392 is a NA study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00470392, a NA study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes
Interventions
- DRUG Imiquimod
- DRUG Clobetasol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-05 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00470392
The ClinicalTrials.gov registry entry for NCT00470392 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Imiquimod is the first listed.
NCT00470392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00470392 about?
NCT00470392 is a clinical study titled "Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis". The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposu...
What is the current status of trial NCT00470392?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2007-05. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00470392?
The interventions under investigation include: Imiquimod (DRUG), Clobetasol (DRUG).
Who is sponsoring clinical trial NCT00470392?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.